Evolv Technologies Holdings, Inc. (NASDAQ:EVLV – Get Free Report) has earned an average recommendation of “Moderate Buy” from the seven research firms that are currently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, four have given a buy recommendation and one has issued a strong buy recommendation on the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $9.1250.
A number of equities analysts recently issued reports on the company. Lake Street Capital increased their price objective on Evolv Technologies from $9.00 to $10.00 and gave the stock a “buy” rating in a report on Friday, November 14th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Evolv Technologies in a research report on Wednesday, October 8th. Finally, Zacks Research raised Evolv Technologies from a “strong sell” rating to a “hold” rating in a report on Friday, October 17th.
Check Out Our Latest Report on Evolv Technologies
Evolv Technologies Stock Up 1.4%
Evolv Technologies (NASDAQ:EVLV – Get Free Report) last issued its quarterly earnings data on Thursday, November 13th. The company reported ($0.01) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.06. Evolv Technologies had a negative net margin of 43.76% and a negative return on equity of 55.11%. The firm had revenue of $42.85 million for the quarter, compared to the consensus estimate of $33.73 million. As a group, equities analysts expect that Evolv Technologies will post -0.27 earnings per share for the current year.
Insider Activity at Evolv Technologies
In related news, Director Kevin M. Charlton acquired 15,000 shares of the stock in a transaction that occurred on Friday, November 21st. The shares were acquired at an average price of $5.68 per share, for a total transaction of $85,200.00. Following the completion of the purchase, the director directly owned 44,081 shares of the company’s stock, valued at $250,380.08. The trade was a 51.58% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, Director Michael Ellenbogen sold 80,745 shares of the company’s stock in a transaction that occurred on Wednesday, October 15th. The stock was sold at an average price of $8.26, for a total value of $666,953.70. Following the completion of the sale, the director owned 2,083,961 shares of the company’s stock, valued at $17,213,517.86. This trade represents a 3.73% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders bought 61,300 shares of company stock worth $363,326 and sold 440,745 shares worth $3,618,954. Company insiders own 11.30% of the company’s stock.
Institutional Trading of Evolv Technologies
A number of hedge funds and other institutional investors have recently modified their holdings of the company. Arizona State Retirement System boosted its stake in Evolv Technologies by 5.7% during the third quarter. Arizona State Retirement System now owns 31,581 shares of the company’s stock valued at $238,000 after buying an additional 1,694 shares in the last quarter. CW Advisors LLC lifted its holdings in Evolv Technologies by 19.0% in the 2nd quarter. CW Advisors LLC now owns 12,614 shares of the company’s stock valued at $79,000 after acquiring an additional 2,014 shares during the last quarter. Victory Capital Management Inc. boosted its position in shares of Evolv Technologies by 16.5% during the 3rd quarter. Victory Capital Management Inc. now owns 15,601 shares of the company’s stock valued at $118,000 after purchasing an additional 2,206 shares in the last quarter. Jones Financial Companies Lllp raised its holdings in shares of Evolv Technologies by 29.1% in the 3rd quarter. Jones Financial Companies Lllp now owns 10,065 shares of the company’s stock worth $77,000 after purchasing an additional 2,266 shares in the last quarter. Finally, BNP Paribas Financial Markets lifted its stake in Evolv Technologies by 38.3% during the second quarter. BNP Paribas Financial Markets now owns 12,985 shares of the company’s stock valued at $81,000 after purchasing an additional 3,596 shares during the last quarter. Institutional investors own 66.65% of the company’s stock.
About Evolv Technologies
Evolv Technologies, Inc is a publicly traded American security technology company that develops and markets AI-driven weapons detection and screening solutions. The company’s proprietary platform combines advanced sensors, computer vision software and machine learning algorithms to identify potential threats—such as firearms and knives—while minimizing false positives and preserving high throughput. Evolv’s systems are designed to replace or supplement traditional metal detectors and manual bag checks in high-traffic venues.
The company’s flagship product, Evolv Express, integrates seamlessly into existing security checkpoints, allowing guests to pass through without stopping or emptying their pockets.
Featured Stories
- Five stocks we like better than Evolv Technologies
- Trump’s new AI budget just passed — one stock could soar
- Bombshell Exposé on China Strikes
- Do not delete, read immediately
- Buy this $2 Gold Stock Before January 1, 2026
- If You Keep Cash In A U.S. Bank Account… Read This NOW
Receive News & Ratings for Evolv Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolv Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
